![Sample our Medicine, Dentistry, Nursing & Allied Health journals, sign in here to start your FREE access for 14 days]({"type":"image" , "src" : "/sda/5944/TOC-Subject-Sample-2021-Medicine-Dentistry-Nursing-Allied-Health.jpg"})
Declaration of Interest
A Nakamura has received research funding from Mitsubishi Tanabe Pharma and Ono Pharmaceutical Co.,Ltd. H Miyoshi has received honoraria for lectures from Astellas Pharma Inc., AstraZeneca, Dainippon Pharma Co, Eli Lilly and Company, Kissei, Mitsubishi Tanabe Pharma Co., Merck Sharp and Dohme, Novartis Pharma, Novo Nordisk Pharma, Takeda Pharmaceutical Co., Ltd., Kowa Pharmaceutical Co., Ltd., Ono Pharmaceutical Co., Ltd., and Sanofi and has received research funding from Astellas Pharma Inc., AstraZeneca, Daiichi Sankyo, Dainippon Pharma Co., Eli Lilly and Company, Mitsubishi Tanabe Pharma Co., Merck Sharp and Dohme, Novo Nordisk Pharma, Sanofi, Takeda Pharmaceutical Co., Ltd., Kowa Pharmaceutical Co., Ltd., Ono Pharmaceutical Co., Ltd., and Taisho Toyama Pharmaceutical Co., Ltd. T Atsumi has received honoraria for lectures from Mitsubishi Tanabe Pharma Co., UCB Japan Co., Ltd., Chugai Pharmaceutical Co., Ltd., Astellas Pharma Inc., Takeda Pharmaceutical Co., Ltd., Pfizer Inc., Eli Lilly and Company, Bristol-Myers Squibb, AbbVie Inc. and Eisai Co., Ltd., and has received research funding from Astellas Pharma Inc., Takeda Pharmaceutical Co., Ltd., Mitsubishi Tanabe Pharma Co., Chugai Pharmaceutical Co., Ltd., Daiichi Sankyo Co. Ltd., Bayer Yakuhin, Ltd., and Eisai Co., Ltd. The authors have no other relevant affiliations or financial involvement with any organization or entity with a financial interest in or financial conflict with the subject matter or materials discussed in the manuscript apart from those disclosed.